These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33272245)

  • 41. ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway.
    Cui Y; Dong YY
    Aging (Albany NY); 2022 Sep; 14(18):7505-7516. PubMed ID: 36126191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway.
    Song R; Tian K; Wang W; Wang L
    Int J Surg; 2015 Aug; 20():80-7. PubMed ID: 25936826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J; Zou Y; Jiang D
    Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.
    Ma J; Huang H; Han Z; Zhu C; Yue B
    Biomed Res Int; 2015; 2015():147468. PubMed ID: 26229955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
    Huang S; Jin A
    J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LINC00968 functions as an oncogene in osteosarcoma by activating the PI3K/AKT/mTOR signaling.
    Liu G; Yuan D; Sun P; Liu W; Wu PF; Liu H; Yu GY
    J Cell Physiol; 2018 Nov; 233(11):8639-8647. PubMed ID: 29904919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
    Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
    Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway.
    Hao L; Liao Q; Tang Q; Deng H; Chen L
    Biochem Biophys Res Commun; 2016 Feb; 470(3):643-649. PubMed ID: 26797271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The expression and function of miRNA-106 in pediatric osteosarcoma.
    Xu M; Zhang YY; Wang HF; Yang GS
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):715-722. PubMed ID: 28272712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isoliquiritigenin Suppresses Osteosarcoma U2OS Cell Proliferation and Invasion by Regulating the PI3K/Akt Signalling Pathway.
    Chen J; Liu C; Yang QQ; Ma RB; Ke Y; Dong F; Wu XE
    Chemotherapy; 2018; 63(3):155-161. PubMed ID: 29936511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro.
    Wang TF; Wang H; Peng AF; Luo QF; Liu ZL; Zhou RP; Gao S; Zhou Y; Chen WZ
    Biochem Biophys Res Commun; 2013 Oct; 440(2):229-34. PubMed ID: 24041695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SLC34A2 Regulates the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells Through PTEN/PI3K/AKT Signaling.
    Liu X; Zhou X; Xu H; He Z; Shi X; Wu S
    DNA Cell Biol; 2017 Sep; 36(9):775-780. PubMed ID: 28777670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway.
    Li B; Yang Y; Jiang S; Ni B; Chen K; Jiang L
    Int J Oncol; 2012 Nov; 41(5):1809-19. PubMed ID: 22948234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [6]-Gingerol enhances the cisplatin sensitivity of gastric cancer cells through inhibition of proliferation and invasion via PI3K/AKT signaling pathway.
    Luo Y; Zha L; Luo L; Chen X; Zhang Q; Gao C; Zhuang X; Yuan S; Qiao T
    Phytother Res; 2019 May; 33(5):1353-1362. PubMed ID: 30811726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
    Liu M; Qi Z; Liu B; Ren Y; Li H; Yang G; Zhang Q
    Oncotarget; 2015 Sep; 6(28):25281-94. PubMed ID: 26325371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Podocalyxin promotes cisplatin chemoresistance in osteosarcoma cells through phosphatidylinositide 3-kinase signaling.
    Huang Z; Huang Y; He H; Ni J
    Mol Med Rep; 2015 Sep; 12(3):3916-3922. PubMed ID: 26017117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.